BI-671800 is a CRTH2 antagonist that treats patients with asthma. BI 671800 is associated with a small improvement in FEV1 in symptomatic controller-naïve asthma patients, and in patients on inhaled corticosteroid (ICS) therapy.
For research use only. We do not sell to patients.
| Name | BI-671800 |
|---|---|
| Iupac Chemical Name | 5-Pyrimidineacetic acid, 4,6-bis(dimethylamino)-2-((4-((4-(trifluoromethyl)benzoyl)amino)phenyl)methyl)- |
| Synonyms | BI-671800; BI 671800; BI671800. |
| Molecular Formula | C25H26F3N5O3 |
| Molecular Weight | 501.5 |
| Smile | CN(C)c1c(c(nc(n1)Cc2ccc(cc2)NC(=O)c3ccc(cc3)C(F)(F)F)N(C)C)CC(=O)O |
| InChiKey | XEOSTBFUCNZKGS-UHFFFAOYSA-N |
| InChi | InChI=1S/C25H26F3N5O3/c1-32(2)22-19(14-21(34)35)23(33(3)4)31-20(30-22)13-15-5-11-18(12-6-15)29-24(36)16-7-9-17(10-8-16)25(26,27)28/h5-12H,13-14H2,1-4H3,(H,29,36)(H,34,35) |
| CAS Number | 1093108-50-9 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |